- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2012
- Public Summary Document (PSD) July 2012 PBAC Meeting - PDF
Aztreonam – July 2012
Aztreonam, powder for inhalation, 75 mg, with diluent, Cayston® - July 2012
Last updated
8 November 2023